{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:34:14Z","timestamp":1792056854386,"version":"4.4.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.autrev.2020.102686","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T02:03:57Z","timestamp":1603418637000},"page":"102686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The NZB\/W\u00a0F1 mouse model for Sj\u00f6gren's syndrome: A historical perspective and lessons learned"],"prefix":"10.1016","volume":"19","author":[{"given":"Harini","family":"Bagavant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Michrowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh S.","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2020.102686_bb0005","series-title":"Autoimmunity: From Bench to Bedside [Internet]","article-title":"Sj\u00f6gren\u2019s syndrome","author":"Sarmiento-Monroy","year":"2013"},{"key":"10.1016\/j.autrev.2020.102686_bb0010","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jbspin.2019.02.004","article-title":"Geoepidemiology of Sjogren\u2019s syndrome in Latin America","volume":"86","author":"Restrepo-Jimenez","year":"2019","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.autrev.2020.102686_bb0015","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.autrev.2015.03.008","article-title":"Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases","volume":"14","author":"Ramos-Casals","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102686_bb0020","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.autrev.2018.05.005","article-title":"Clinical and immunological parameters of Sj\u00f6gren\u2019s syndrome","volume":"17","author":"Psianou","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102686_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clim.2019.04.009","article-title":"Sjogren\u2019s syndrome: an update on disease pathogenesis, clinical manifestations and treatment","volume":"203","author":"Vivino","year":"2019","journal-title":"Clin Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2020.102686_bb0030","first-page":"102","article-title":"How immunological profile drives clinical phenotype of primary Sjogren\u2019s syndrome at diagnosis: analysis of 10,500 patients (Sjogren big data project)","volume":"36","author":"Brito-Zeron","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2020.102686_bb0035","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/rheumatology\/kez335","article-title":"Unique Sjogren\u2019s syndrome patient subsets defined by molecular features","volume":"59","author":"James","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2020.102686_bb0040","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ng.2792","article-title":"Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sj\u00f6gren\u2019s syndrome","volume":"45","author":"Lessard","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2020.102686_bb0045","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1001\/jama.2013.278448","article-title":"Autoantibodies present before symptom onset in primary Sj\u00f6gren syndrome","volume":"310","author":"Jonsson","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2020.102686_bb0050","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/art.39214","article-title":"Prediction of Sj\u00f6gren\u2019s syndrome years before diagnosis and identification of patients with early onset and severe disease course by autoantibody profiling","volume":"67","author":"Theander","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2020.102686_bb0055","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/BOR.0000000000000631","article-title":"The dark side of Sj\u00f6gren\u2019s syndrome: the possible pathogenic role of infections","volume":"31","author":"Bartoloni","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102686_bb0060","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/BOR.0000000000000622","article-title":"The role of Epstein-Barr virus infection in primary Sj\u00f6gren\u2019s syndrome","volume":"31","author":"Ma\u015bli\u0144ska","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102686_bb0065","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/clim.2002.5189","article-title":"Pathogenesis of Sj\u00f6gren\u2019s syndrome: characteristics of different mouse models for autoimmune exocrinopathy","volume":"103","author":"van Blokland","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2020.102686_bb0070","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.2174\/1381612821666150316120024","article-title":"Mouse models of primary Sjogren\u2019s syndrome","volume":"21","author":"Park","year":"2015","journal-title":"Curr Pharm Des"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2020.102686_bb0075","first-page":"209","article-title":"Animal models of Sj\u00f6gren\u2019s syndrome: an update","volume":"37","author":"Xiao","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2020.102686_bb0080","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/art.1780360309","article-title":"Preliminary criteria for the classification of Sj\u00f6gren\u2019s syndrome. Results of a prospective concerted action supported by the European Community","volume":"36","author":"Vitali","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102686_bb0085","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European consensus group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102686_bb0090","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data- driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2020.102686_bb0095","first-page":"57203","article-title":"A method for the measurement of salivary gland function in mice","volume":"131","author":"Bagavant","year":"2018","journal-title":"J Vis Exp"},{"key":"10.1016\/j.autrev.2020.102686_bb0100","first-page":"9","article-title":"Spontaneous anemia in mice of the NZB\/BL strain","volume":"37","author":"Bielschowsky","year":"1959","journal-title":"Proc Univ Otago Med Sch"},{"key":"10.1016\/j.autrev.2020.102686_bb0105","first-page":"17","article-title":"Positive lupus erythematosis tests in a cross-bred strain of mice NZB\/BL-NZY\/BL","volume":"39","author":"Helyer","year":"1961","journal-title":"Proc Univ Otago Med Sch"},{"key":"10.1016\/j.autrev.2020.102686_bb0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/197197a0","article-title":"Renal disease associated with positive lupus erythematosus tests in a cross-bred strain of mice","volume":"197","author":"Helyer","year":"1963","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2020.102686_bb0115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0065-2776(08)60444-7","article-title":"The immunology and pathology of NZB mice","volume":"9","author":"Howie","year":"1968","journal-title":"Adv Immunol"},{"key":"10.1016\/j.autrev.2020.102686_bb0120","first-page":"671","article-title":"A laboratory model for Sjogren\u2019s syndrome","volume":"52","author":"Kessler","year":"1968","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2020.102686_bb0125","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/sarh.2000.7173","article-title":"The pathogenesis of autoimmunity in New Zealand mice","volume":"29","author":"Borchers","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102686_bb0130","doi-asserted-by":"crossref","first-page":"10168","DOI":"10.1073\/pnas.91.21.10168","article-title":"Lupus susceptibility loci in New Zealand mice","volume":"91","author":"Kono","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2020.102686_bb0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-065X.1995.tb00065.x","article-title":"Genetic contributions to lupus-like disease in (NZB x NZW)F1 mice","volume":"144","author":"Drake","year":"1995","journal-title":"Immunol Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2020.102686_bb0140","first-page":"121","article-title":"Severe, life-threatening phenotype of primary Sj\u00f6gren\u2019s syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS registry)","volume":"36","author":"Flores-Ch\u00e1vez","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2020.102686_bb0145","first-page":"1","article-title":"Keratitis filiformis bei hypofunction der Tr\u00e4nendr\u00fcsen. A new conception of keratoconjunctivitis sicca (keratitis filiformis in hypofunction of the lacrimal glands)","author":"Sj\u00f6gren","year":"1933","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.autrev.2020.102686_bb0150","first-page":"911","article-title":"Focal adenitis in salivary and lacrimal glands","volume":"56","author":"Waterhouse","year":"1963","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.autrev.2020.102686_bb0155","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0030-4220(66)90236-2","article-title":"Sjogren\u2019s syndrome. Report of a case","volume":"21","author":"Calman","year":"1966","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.autrev.2020.102686_bb0160","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/jcp.21.5.656","article-title":"Labial salivary gland biopsy in Sjogren\u2019s disease","volume":"21","author":"Chisholm","year":"1968","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.autrev.2020.102686_bb0165","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/annrheumdis-2016-210448","article-title":"Standardisation of labial salivary gland histopathology in clinical trials in primary Sj\u00f6gren\u2019s syndrome","volume":"76","author":"Fisher","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102686_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211142","article-title":"Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sj\u00f6gren\u2019s syndrome minor salivary glands","volume":"14","author":"Carubbi","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102686_bb0175","first-page":"471","article-title":"A clinicopathologic study of Mikulicz\u2019s disease","volume":"29","author":"Morgan","year":"1953","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2020.102686_bb0180","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00005792-196505000-00001","article-title":"Sj\u00f6gren\u2019s syndrome. A clinical, pathological, and serological study of sixty-two cases","volume":"44","author":"Bloch","year":"1965","journal-title":"Medicine"},{"key":"10.1016\/j.autrev.2020.102686_bb0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0090-1229(87)90176-0","article-title":"Immunohistochemical characterization of sialadenitis in NZB X NZW F1 mice","volume":"42","author":"Jonsson","year":"1987","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2020.102686_bb0190","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/jcpa.2001.0493","article-title":"Relationship between sialoadenitis and periductal laminin expression in the submandibular salivary gland of NZBxNZWF(1) mice","volume":"125","author":"Hayashi","year":"2001","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.autrev.2020.102686_bb0195","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00428-008-0627-4","article-title":"Ultrastructure of myoepithelial cells as a target cell in sialoadenitis of submandibular glands of lupus-prone female NZBxNZWF1 mice","volume":"453","author":"Hayashi","year":"2008","journal-title":"Virchows Arch"},{"key":"10.1016\/j.autrev.2020.102686_bb0200","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0030-4220(74)90417-4","article-title":"The histopathology of Sj\u00f6gren\u2019s syndrome in labial salivary gland biopsies","volume":"37","author":"Greenspan","year":"1974","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.autrev.2020.102686_bb0205","first-page":"214","article-title":"The presence of cytotoxic autoantibody to lacrimal gland cells in NZB\/W mice","volume":"26","author":"Ohashi","year":"1985","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2020.102686_bb0210","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-0714.2008.00730.x","article-title":"Systemic treatment of anti-CD4CD25 T cell monoclonal antibody exacerbates sialoadenitis in submandibular glands during the early life in lupus-prone female NZB x NZWF mice","volume":"38","author":"Hayashi","year":"2009","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.autrev.2020.102686_bb0215","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1600-0560.2009.01368.x","article-title":"Xerostomia in Sjogren\u2019s syndrome and lupus erythematosus: a comparative histological and immunofluorescence study of minor salivary glands alterations","volume":"37","author":"Fernandes","year":"2010","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.autrev.2020.102686_bb0220","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1002\/art.20371","article-title":"Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sj\u00f6gren\u2019s syndrome patients by use of a transfected cell line assay","volume":"50","author":"Gao","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102686_bb0225","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/annrheumdis-2014-206297","article-title":"Interaction between innate immunity and Ro52-induced antibody causes Sjogren\u2019s syndrome-like disorder in mice","volume":"75","author":"Szczerba","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102686_bb0230","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/BOR.0b013e32832eba21","article-title":"Pathogenesis of Sjogren\u2019s syndrome","volume":"21","author":"Nikolov","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102686_bb0235","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1600-0714.1991.tb00409.x","article-title":"An investigation of parotid gland function and histopathology in autoimmune disease-prone mice of different age groups","volume":"20","author":"Wolff","year":"1991","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.autrev.2020.102686_bb0240","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/art.39497","article-title":"Brief report: patients with primary Sj\u00f6gren\u2019s syndrome who are positive for autoantibodies to tripartite motif-containing protein 38 show greater disease severity","volume":"68","author":"Wolska","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2020.102686_bb0245","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/art.23368","article-title":"Inflammatory stimuli accelerate Sjogren\u2019s syndrome-like disease in (NZB x NZW)F1 mice","volume":"58","author":"Deshmukh","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102686_bb0250","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/path.1711480308","article-title":"Light and ultrastructural features of lymphoepithelial lesions of the salivary glands in Mikulicz\u2019s disease","volume":"148","author":"Chaudhry","year":"1986","journal-title":"J Pathol"},{"key":"10.1016\/j.autrev.2020.102686_bb0255","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3109\/00016487809121454","article-title":"Ultrastructural observations on the parotitis autoimmunica in the NZB\/NZW hybrid mice","volume":"85","author":"Carlsoo","year":"1978","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.autrev.2020.102686_bb0260","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00455876","article-title":"The autoimmune submandibular sialoadenitis of the NZB\/NZW hybrid mice. A light and electron microscopical investigation","volume":"225","author":"Carlsoo","year":"1979","journal-title":"Arch Otorhinolaryngol"},{"key":"10.1016\/j.autrev.2020.102686_bb0265","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10735-017-9751-2","article-title":"Reduced myofilament component in primary Sjogren\u2019s syndrome salivary gland myoepithelial cells","volume":"49","author":"Sisto","year":"2018","journal-title":"J Mol Histol"},{"key":"10.1016\/j.autrev.2020.102686_bb0270","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/08916934.2018.1446525","article-title":"Signalling pathways identified in salivary glands from primary Sj\u00f6gren\u2019s syndrome patients reveal enhanced adipose tissue development","volume":"51","author":"Aqrawi","year":"2018","journal-title":"Autoimmunity"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2020.102686_bb0275","first-page":"80","article-title":"Minor salivary gland fibrosis in Sjogren\u2019s syndrome is elevated, associated with focus score and not solely a consequence of aging","volume":"36","author":"Leehan","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2020.102686_bb0280","first-page":"45","article-title":"ICAM-1 expression on endothelium and systemic cytokine production in cutaneous neutrophilic leukocytoclastic vasculitis in NZBxNZWF1 mice","volume":"20","author":"Hayashi","year":"2005","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.autrev.2020.102686_bb0285","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2013.11.001","article-title":"A comprehensive review of autoantibodies in primary Sj\u00f6gren\u2019s syndrome: clinical phenotypes and regulatory mechanisms","volume":"51","author":"Kyriakidis","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102686_bb0290","doi-asserted-by":"crossref","DOI":"10.21037\/jlpm.2018.08.05","article-title":"Prognostic value of Sj\u00f6gren\u2019s syndrome autoantibodies","volume":"3","author":"Scofield","year":"2018","journal-title":"J Lab Precis Med"},{"key":"10.1016\/j.autrev.2020.102686_bb0295","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/art.1780180312","article-title":"Selective suppression of autoantibody responses in NZB\/NZW mice treated with long-term cyclophosphamide","volume":"18","author":"Walker","year":"1975","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102686_bb0300","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/annrheumdis-2018-214436","article-title":"Clinical relevance of HEp-2 indirect immunofluorescent patterns: the international consensus on ANA patterns (ICAP) perspective","volume":"78","author":"Damoiseaux","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102686_bb0305","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00360410","article-title":"Structure and function of La and Ro RNPs","volume":"14","author":"Pruijn","year":"1990","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.autrev.2020.102686_bb0310","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbrc.2005.11.029","article-title":"Autoantigen Ro52 is an E3 ubiquitin ligase","volume":"339","author":"Wada","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2020.102686_bb0315","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1046\/j.1432-1327.2000.01298.x","article-title":"Analysis of the molecular composition of Ro ribonucleoprotein complexes. Identification of novel Y RNA-binding proteins","volume":"267","author":"Fabini","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.autrev.2020.102686_bb0320","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/art.1780270206","article-title":"Sj\u00f6gren\u2019s syndrome in MRL\/l and MRL\/n mice","volume":"27","author":"Hoffman","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102686_bb0325","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.4049\/jimmunol.164.12.6655","article-title":"Ro60 peptides induce antibodies to similar epitopes shared among lupus- related autoantigens","volume":"164","author":"Deshmukh","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102686_bb0330","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/08916934.2013.798651","article-title":"A novel antagonist of toll-like receptors 7, 8 and 9 suppresses lupus disease-associated parameters in NZBW\/F1 mice","volume":"46","author":"Zhu","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2020.102686_bb0335","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00784-018-2545-4","article-title":"Clinical and diagnostic significance of serum immunoglobulin A rheumatoid factor in primary Sjogren\u2019s syndrome","volume":"23","author":"Lee","year":"2019","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.autrev.2020.102686_bb0340","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s10067-019-04438-z","article-title":"Usefulness of rheumatoid factor as an immunological and prognostic marker in PSS patients","volume":"38","author":"Ma\u015bli\u0144ska","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102686_bb0345","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1084\/jem.148.5.1198","article-title":"Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains","volume":"148","author":"Andrews","year":"1978","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2020.102686_bb0350","doi-asserted-by":"crossref","DOI":"10.1186\/ar4206","article-title":"Germline deletion of \u03b22 microglobulin or CD1d reduces anti-phospholipid antibody, but increases autoantibodies against non-phospholipid antigens in the NZB\/W F1 model of lupus","volume":"15","author":"Singh","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2020.102686_bb0355","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","article-title":"The cryoglobulinaemias","volume":"379","author":"Ramos-Casals","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2020.102686_bb0360","doi-asserted-by":"crossref","first-page":"102316","DOI":"10.1016\/j.jaut.2019.102316","article-title":"Predictive markers of lymphomagenesis in Sj\u00f6gren\u2019s syndrome: from clinical data to molecular stratification","volume":"104","author":"Kapsogeorgou","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102686_bb0365","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1136\/ard.2003.011890","article-title":"Anti- telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases","volume":"63","author":"Salonen","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102686_bb0370","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2010.05.004","article-title":"Immunological profile in primary Sjogren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease","volume":"9","author":"Fauchais","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102686_bb0375","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001033","article-title":"Anti- RNP positivity in primary Sjogren\u2019s syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement","volume":"5","author":"Abbara","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2020.102686_bb0380","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0714.2008.00700.x","article-title":"Activation of innate immune responses through toll-like receptor 3 causes a rapid loss of salivary gland function","volume":"38","author":"Deshmukh","year":"2009","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.autrev.2020.102686_bb0385","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-0714.2012.01181.x","article-title":"Salivary gland hypofunction induced by activation of innate immunity is dependent on type I interferon signaling","volume":"42","author":"Nandula","year":"2013","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.autrev.2020.102686_bb0390","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1601-0825.2011.01839.x","article-title":"Activation of innate immunity accelerates sialoadenitis in a mouse model for Sj\u00f6gren\u2019s syndrome-like disease","volume":"17","author":"Nandula","year":"2011","journal-title":"Oral Dis"},{"key":"10.1016\/j.autrev.2020.102686_bb0395","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1073\/pnas.63.4.1102","article-title":"The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic- polycytidylic acid","volume":"63","author":"Steinberg","year":"1969","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2020.102686_bb0400","first-page":"43","article-title":"Making the diagnosis of Sj\u00f6gren\u2019s syndrome in patients with dry eye","volume":"10","author":"Beckman","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.autrev.2020.102686_bb0405","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/archopht.1971.00990050213016","article-title":"Eye changes in autoimmune NZB and NZB x NZW mice. Comparison with Sjogren\u2019s syndrome","volume":"85","author":"Kessler","year":"1971","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.autrev.2020.102686_bb0410","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1076\/ceyr.23.3.199.5468","article-title":"Lacrimal gland fluid secretion and lymphocytic infiltration in the NZB\/W mouse model of Sjogren\u2019s syndrome","volume":"23","author":"Paranyuk","year":"2001","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.autrev.2020.102686_bb0415","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1076\/ceyr.25.4.253.13489","article-title":"Differences in stimulus induced calcium increases in lacrimal gland acinar cells from normal and NZB\/NZW F1 female mice","volume":"25","author":"Walcott","year":"2002","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.autrev.2020.102686_bb0420","doi-asserted-by":"crossref","first-page":"13953","DOI":"10.1038\/srep13953","article-title":"IP3R deficit underlies loss of salivary fluid secretion in Sj\u00f6gren\u2019s syndrome","volume":"5","author":"Teos","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2020.102686_bb0425","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/acr2.1033","article-title":"Reproducibility of ocular surface staining in the assessment of Sj\u00f6gren syndrome- related Keratoconjunctivitis sicca: implications on disease classification","volume":"1","author":"Rasmussen","year":"2019","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.autrev.2020.102686_bb0430","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3109\/02713688709025234","article-title":"Lacrimal gland, cornea, and tear film in the NZB\/NZW F1 hybrid mouse","volume":"6","author":"Gilbard","year":"1987","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.autrev.2020.102686_bb0435","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0002-9343(79)91110-0","article-title":"Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis","volume":"66","author":"Moutsopoulos","year":"1979","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2020.102686_bb0440","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/art.20093","article-title":"Sj\u00f6gren\u2019s syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sj\u00f6gren\u2019s syndrome","volume":"50","author":"Manoussakis","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102686_bb0445","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3899\/jrheum.090804","article-title":"Secondary Sjogren\u2019s syndrome in systemic lupus erythematosus defines a distinct disease subset","volume":"37","author":"Baer","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102686_bb0450","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/rheumatology\/keaa009","article-title":"Equal rights in autoimmunity: is Sj\u00f6gren\u2019s syndrome ever \u201csecondary\u201d?","volume":"59","author":"Kollert","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2020.102686_bb0455","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.rdc.2016.03.005","article-title":"Polyautoimmunity in Sj\u00f6gren syndrome","volume":"42","author":"Anaya","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2020.102686_bb0460","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jaut.2012.05.008","article-title":"Sj\u00f6gren\u2019s syndrome at the crossroad of polyautoimmunity","volume":"39","author":"Amador-Patarroyo","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102686_bb0465","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/15027732.1986.12461404","article-title":"Symptomatic secondary Sj\u00f6gren\u2019s syndrome in patients with systemic lupus erythematosus (SLE). Relation to anti- SS-A and anti-SS-B autoantibodies","volume":"61","author":"Jonsson","year":"1986","journal-title":"Scand J Rheumatol Suppl"},{"key":"10.1016\/j.autrev.2020.102686_bb0470","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10067-007-0720-0","article-title":"Clinical and laboratory profiles of systemic lupus erythematosus associated with Sj\u00f6gren syndrome in China: a study of 542 patients","volume":"27","author":"Pan","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102686_bb0475","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3899\/jrheum.190250","article-title":"Sj\u00f6gren syndrome in systemic lupus erythematosus: a subset characterized by a systemic inflammatory state","volume":"47","author":"Ruacho","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102686_bb0480","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4049\/jimmunol.1900043","article-title":"Treatment with a CD40 antagonist antibody reverses severe proteinuria and loss of saliva production and restores glomerular morphology in murine systemic lupus erythematosus","volume":"203","author":"Perper","year":"2019","journal-title":"J Immunol"},{"issue":"suppl.10","key":"10.1016\/j.autrev.2020.102686_bb0485","article-title":"The novel Anti-CD40 monoclonal antibody CFZ533 shows beneficial effects in patients with primary Sj\u00f6gren\u2019s syndrome: a phase IIA double-blind, placebo-controlled randomized trial [abstract]","volume":"69","author":"Fisher","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2020.102686_bb0490","unstructured":"ClinicalTrials.gov [Internet]. National Library of Medicine (US). August 1, 2018. Identifier NCT03610516. Safety, pharmacokinetics and preliminary efficacy study of CFZ533 in patients with lupus nephritis. Available from: www.clinicaltrials.gov\/ct2\/show\/N n.d. Accessed June 8, 2020."},{"key":"10.1016\/j.autrev.2020.102686_bb0495","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/clin.1995.1128","article-title":"Effects of calorie restriction on transforming growth factor beta 1 and proinflammatory cytokines in murine Sjogren\u2019s syndrome","volume":"76","author":"Chandrasekar","year":"1995","journal-title":"Clin Immunol Immunopathol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220302639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220302639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:19:57Z","timestamp":1761599997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997220302639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":99,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1568997220302639"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102686","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The NZB\/W\u00a0F1 mouse model for Sj\u00f6gren's syndrome: A historical perspective and lessons learned","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102686","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102686"}}